133 related articles for article (PubMed ID: 7660281)
1. Effect of 4-aminopyridine in acute spinal cord injury.
Haghighi SS; Pugh SL; Perez-Espejo MA; Oro JJ
Surg Neurol; 1995 May; 43(5):443-7. PubMed ID: 7660281
[TBL] [Abstract][Full Text] [Related]
2. Effect of 4-aminopyridine and single-dose methylprednisolone on functional recovery after a chronic spinal cord injury.
Haghighi SS; Clapper A; Johnson GC; Stevens A; Prapaisilp A
Spinal Cord; 1998 Jan; 36(1):6-12. PubMed ID: 9471130
[TBL] [Abstract][Full Text] [Related]
3. Parallel Evaluation of Two Potassium Channel Blockers in Restoring Conduction in Mechanical Spinal Cord Injury in Rat.
Page JC; Park J; Chen Z; Cao P; Shi R
J Neurotrauma; 2018 May; 35(9):1057-1068. PubMed ID: 29228863
[TBL] [Abstract][Full Text] [Related]
4. Acrolein-mediated conduction loss is partially restored by K⁺ channel blockers.
Yan R; Page JC; Shi R
J Neurophysiol; 2016 Feb; 115(2):701-10. PubMed ID: 26581866
[TBL] [Abstract][Full Text] [Related]
5. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury.
Hayes KC; Potter PJ; Wolfe DL; Hsieh JT; Delaney GA; Blight AR
J Neurotrauma; 1994 Aug; 11(4):433-46. PubMed ID: 7837283
[TBL] [Abstract][Full Text] [Related]
6. 4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury.
McBride JM; Smith DT; Byrn SR; Borgens RB; Shi R
Neuroscience; 2007 Aug; 148(1):44-52. PubMed ID: 17629412
[TBL] [Abstract][Full Text] [Related]
7. Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease.
Smith DT; Shi R; Borgens RB; McBride JM; Jackson K; Byrn SR
Eur J Med Chem; 2005 Sep; 40(9):908-17. PubMed ID: 16055230
[TBL] [Abstract][Full Text] [Related]
8. The effects of taxol, methylprednisolone, and 4-aminopyridine in compressive spinal cord injury: a qualitative experimental study.
Perez-Espejo MA; Haghighi SS; Adelstein EH; Madsen R
Surg Neurol; 1996 Oct; 46(4):350-7. PubMed ID: 8876716
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
[TBL] [Abstract][Full Text] [Related]
10. Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine.
Shi R; Kelly TM; Blight AR
Exp Neurol; 1997 Dec; 148(2):495-501. PubMed ID: 9417828
[TBL] [Abstract][Full Text] [Related]
11. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury.
Hayes KC; Blight AR; Potter PJ; Allatt RD; Hsieh JT; Wolfe DL; Lam S; Hamilton JT
Paraplegia; 1993 Apr; 31(4):216-24. PubMed ID: 8493036
[TBL] [Abstract][Full Text] [Related]
12. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.
Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM
Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901
[TBL] [Abstract][Full Text] [Related]
13. Effect of lidocaine treatment on acute spinal cord injury.
Haghighi SS; Chehrazi BB; Higgins RS; Remington WJ; Wagner FC
Neurosurgery; 1987 Apr; 20(4):536-41. PubMed ID: 3587543
[TBL] [Abstract][Full Text] [Related]
14. Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter.
Sun W; Smith D; Fu Y; Cheng JX; Bryn S; Borgens R; Shi R
J Neurophysiol; 2010 Jan; 103(1):469-78. PubMed ID: 19923250
[TBL] [Abstract][Full Text] [Related]
15. Assessment of axonal dysfunction in an in vitro model of acute compressive injury to adult rat spinal cord axons.
Fehlings MG; Nashmi R
Brain Res; 1995 Apr; 677(2):291-9. PubMed ID: 7552255
[TBL] [Abstract][Full Text] [Related]
16. Changes in pharmacological sensitivity of the spinal cord to potassium channel blockers following acute spinal cord injury.
Fehlings MG; Nashmi R
Brain Res; 1996 Oct; 736(1-2):135-45. PubMed ID: 8930318
[TBL] [Abstract][Full Text] [Related]
17. Clinically Relevant Levels of 4-Aminopyridine Strengthen Physiological Responses in Intact Motor Circuits in Rats, Especially After Pyramidal Tract Injury.
Sindhurakar A; Mishra AM; Gupta D; Iaci JF; Parry TJ; Carmel JB
Neurorehabil Neural Repair; 2017 Apr; 31(4):387-396. PubMed ID: 28107804
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic value of 21-aminosteroid U74389F in acute spinal cord injury.
Haghighi SS; Hall ED; Geng XZ; Oro JJ; Johnson GC
Neurol Res; 1993 Oct; 15(5):321-6. PubMed ID: 7905606
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels.
Nashmi R; Fehlings MG
Brain Res Brain Res Rev; 2001 Dec; 38(1-2):165-91. PubMed ID: 11750932
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury.
Süzer T; Coskun E; Islekel H; Tahta K
Spinal Cord; 1999 Jul; 37(7):480-4. PubMed ID: 10438114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
